Literature DB >> 15047999

Management of severe falciparum malaria.

P Njuguna1, C Newton.   

Abstract

Plasmodium falciparum is the most common cause of severe and life-threatening malaria. Falciparum malaria causes over one million deaths every year. In Africa, a vast majority of these deaths occur in children under five years of age. The presentation of severe malaria varies with age and geographical distribution. The mortality rate is higher in adults than in children but African children develop neuro-cognitive sequelae following severe malaria more frequently. The management of severe malaria includes prompt administration of appropriate parenteral anti-malarial agents and early recognition and treatment of the complications. In children, the complications include metabolic acidosis (often caused by hypovolaemia), hypoglycaemia, hyperlacticacidaemia, severe anaemia, seizures and raised intracranial pressure. In adults, renal failure and pulmonary oedema are more common causes of death. In contrast, concomitant bacterial infections occur more frequently in children and are associated with mortality in children. Admission to critical or intensive care units may help reduce the mortality, and the frequency and severity of sequelae related to severe malaria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047999

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  9 in total

Review 1.  Innate immunity to malaria-The role of monocytes.

Authors:  Katherine R Dobbs; Juliet N Crabtree; Arlene E Dent
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

2.  Erythrocytapheresis in the emergency management of severe falciparum malaria.

Authors:  Luciano Santana-Cabrera; Manuela Fernández Arroyo; Fayna Rodríguez González; Manuel Sánchez Palacios
Journal:  J Emerg Trauma Shock       Date:  2010-04

3.  High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.

Authors:  Climent Casals-Pascual; Richard Idro; Nimmo Gicheru; Samson Gwer; Barnes Kitsao; Evelyn Gitau; Robert Mwakesi; David J Roberts; Charles R J C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

4.  Severe imported malaria in an intensive care unit: a review of 59 cases.

Authors:  Lurdes C Santos; Cândida F Abreu; Sandra M Xerinda; Margarida Tavares; Raquel Lucas; António C Sarmento
Journal:  Malar J       Date:  2012-03-29       Impact factor: 2.979

Review 5.  Global distribution of infectious diseases requiring intensive care.

Authors:  Raul E Istúriz; Jaime Torres; José Besso
Journal:  Crit Care Clin       Date:  2006-07       Impact factor: 3.598

6.  Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis.

Authors:  Samuel Eneọjọ Abah; Florence Burté; Sandrine Marquet; Biobele J Brown; Francis Akinkunmi; Gbeminiyi Oyinloye; Nathaniel K Afolabi; Samuel Omokhodion; Ikeoluwa Lagunju; Wuraola A Shokunbi; Mats Wahlgren; Hélia Dessein; Laurent Argiro; Alain J Dessein; Boris Noyvert; Lilian Hunt; Greg Elgar; Olugbemiro Sodeinde; Anthony A Holder; Delmiro Fernandez-Reyes
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

7.  Correlation of malaria parasitaemia with peripheral blood monocyte to lymphocyte ratio as indicator of susceptibility to severe malaria in Ghanaian children.

Authors:  Samuel Antwi-Baffour; Ransford Kyeremeh; Dorcas Buabeng; Jonathan Kofi Adjei; Claudia Aryeh; George Kpentey; Mahmood Abdulai Seidu
Journal:  Malar J       Date:  2018-11-12       Impact factor: 2.979

8.  Treatment outcome and factors associated with mortality due to malaria in Munini District Hospital, Rwanda in 2016-2017: Retrospective cross-sectional study.

Authors:  François Hakizayezu; Jared Omolo; Emmanuel Biracyaza; Joseph Ntaganira
Journal:  Front Public Health       Date:  2022-08-09

9.  Incidence, causes and phenotypes of acute seizures in Kenyan children post the malaria-decline period.

Authors:  George K Serem; Charles Rjc Newton; Symon M Kariuki
Journal:  BMC Neurol       Date:  2015-10-06       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.